DEA Calls for Fewer Opioids, More Cannabis In 2019

The Justice Department and Drug Enforcement Agency announced in a news release yesterday the agencies’ new goal for 2019: to reduce production of the nation’s six most frequently abused opioids by an average of ten percent. Additionally, according to a Tom Angell Forbes report, the DEA will call for the quintupling of research-grade cannabis next year, from about 1,000 […]

Read More - -

Tags: , , ,

First FDA-Approved CBD Medication to Cost More than $32,000 Per Year

GW Pharmaceuticals has revealed the expected consumer price for Epidiolex, the first cannabidiol-based medication to be approved by the FDA, according to a Business Insider report. At a price tag of about $32,500 per year, it won’t be cheap, but company representatives said in a phone call with investors this week that its cost reflects that of […]

Read More - -

Tags: , , , ,

DEA, FBI Agents Raid Suspected Illegal Cannabis Growers in Colorado

DEA and FBI agents coordinated a massive raid early Thursday morning against more than a dozen suspected illegal cannabis grow sites throughout the Denver metro area, The Denver Post reports. The grows were reportedly targeted for the illegal growing and distribution of cannabis across state lines. Deanne Rueter — the DEA spokesperson in Denver, Colorado — […]

Read More - -

Tags: , , , , ,

U.S. Cannabis Seizures Falling; Data Suggests Shrinking Illicit Market

GreenWave Advisors has analyzed data from the DEA and Homeland Security regarding cannabis plant seizures over the last several years and determined that the illicit market for cannabis in the U.S. is shrinking, according to a High Times report. Cannabis consultant Dustin Moore said the data could indicate a variety of causes, including a shift from imported illegal […]

Read More - -

Tags: ,

DEA’s Acting Director to Retire in Two Weeks

Robert Patterson, the acting head of the Drug Enforcement Administration, has announced that he is retiring in two weeks, according to a Washington Post report.  Patterson, who has worked at the DEA for 30 years, announced his retirement to staff on Monday via email. He said his role as the temporary director had become more difficult and that […]

Read More - -

Tags: ,

Likely Outcomes of the 9th Circuit Court of Appeals Siding with the DEA

The Federal Court of Appeals in San Francisco ruled in an unpublished Memorandum of Disposition this week that the Drug Enforcement Administration’s December 2016 Marijuana Extract rule change stands. The rule change added a new code number to the DEA rules for “Marihuana Extracts” to make it easier for the DEA to track and trace […]

Read More - -

Tags: , , ,

Court Rules in Favor of DEA in CBD Lawsuit

Ninth Circuit appeals court judges have ruled against the Hemp Industries Association in their bid to overturn a move by the Drug Enforcement Agency to classify CBD as a Schedule I substance under the Controlled Substances Act. The new rule took effect Jan. 13, 2017. In the April 30 ruling, the panel of three judges […]

Read More - -

Tags: , ,

McConnell’s Bill Would Normalize the Hemp Industry

Last week, Senate Majority Leader Mitch McConnell (R-KY) took to the chamber floor and laid out his case for the Hemp Farming Act of 2018, calling hemp a cash crop for the nation’s struggling farmers, a modernization of federal law, a “new spark” for the U.S. economy. McConnell was also the driving force securing the […]

Read More - -

Tags: , , , , , , ,

Federal Case Challenging Constitutionality of Cannabis Prohibition Heads Back to Court on Valentine’s Day

In case you missed it, there is a lawsuit against the Department of Justice, the Drug Enforcement Agency, and Attorney General Jeff Sessions – the text of which reveals the history of the 12,000-year relationship between humans and cannabis and how prohibition not only negatively affects the plaintiffs but potentially all humankind. The suit is […]

Read More - -

Tags: , , , ,

DEA Spokesman: Agency Not Going to ‘Break Down Door’ of Parents Administering CBD to their Children

In an interview with Indiana’s WTHR, Drug Enforcement Agency spokesperson Rusty Payne admitted that while parents giving CBD oil to their children are violating federal law, it is unlikely they will face federal prosecution for their actions. “WTHR: What would you tell the mom and dad who are buying this stuff and giving it to […]

Read More - -

Tags: , ,

Sessions: ‘Healthy’ for Feds to Approve More Cannabis Research Applications

During a Senate Judiciary Committee oversight hearing, Attorney General Jeff Sessions admitted that it would “be healthy to have some more competition” in the federal government’s cannabis research program, noting that there are currently 26 supplier applications before the Drug Enforcement Agency from entities interested in growing cannabis for federal medicinal research. “Each one of […]

Read More - -

Tags: , ,

DEA Destroyed 5M Plants, Arrested 5,657 People in 2016 Cannabis Eradication Efforts

According to the Drug Enforcement Agency’s 2016 Final Domestic Cannabis Eradication/Suppression Program report, the agency destroyed nearly 5 million outdoor-cultivated cannabis plants and seized more than $51.9 million in assets linked to illegal cannabis operations in the U.S. The federal law enforcement agency eradicated a total of 5,528 illegal outdoor cannabis cultivation sites in 2016, […]

Read More - -

Tags: , ,

Uncomfortable with Trump, Acting DEA Chief Chuck Rosenberg Announces Resignation

The acting head of the Drug Enforcement Agency Chuck Rosenberg announced his intent to resign yesterday, citing concerns that President Donald Trump holds little respect for the law, the New York Times reports. Mr. Rosenberg was originally appointed by President Barack Obama following the 2015 resignation of former DEA Chief Michele Leonhart. Though he was never friendly […]

Read More - -

Tags: , ,

House Committee Blocks All Cannabis-Related Budget Amendment Votes

The Republican-controlled House Rules Committee has blocked multiple cannabis-related amendments from receiving consideration by the full chamber, effectively preventing the House from offering the industry protection from the Justice Department. The quashed amendments include: protections for state-approved hemp programs and banks choosing to do business with the cannabis industry; the Rohrabacher-Blumenauer amendment, which prevents the feds […]

Read More - -

Tags: , , , ,

Lawsuit Claims Feds Using IRS as Investigation Arm of DEA, DoJ in Colorado

Lawyers for Silt, Colorado’s Rifle Remedies are claiming in a lawsuit that the Internal Revenue Service is using audits to conduct investigations of legal medical cannabis businesses at the behest of the Department of Justice, the Denver Post reports. The IRS calls the claim illogical and baseless, saying his requests for information from the Marijuana […]

Read More - -

Tags: , , , ,

FDA Requests Public Comments on Therapeutic Value of CBD

The U.S. Food and Drug Administration (FDA) has put out a call for public comments regarding the therapeutic values and potential for abuse of several substances, including cannabidiol or CBD. According to a document released by the FDA, the agency will consider any submitted statements while preparing their response to the World Health Organization (WHO) regarding […]

Read More - -

Tags: , ,

Possession Charges from 4/20 Capitol Rally Dropped Against DCMJ Founder

The co-founder of D.C. Marijuana Justice, Adam Eidinger, had possession charges that were levied against him following his arrest during an Apr. 20 demonstration in Washington, D.C. dropped after the Drug Enforcement Agency determined that the 78 joints found in his possession were less than the 2 ounces allowed under the District’s adult-use laws, the […]

Read More - -

Tags: , , ,

Justice Department Allegedly Blocking DEA-Backed Cannabis Research Applications

The Justice Department, at the behest of Attorney General Jeff Sessions, has actively blocked the Drug Enforcement Agency from moving forward on 25 applications to grow cannabis for research purposes, the Washington Post reports. The DEA began accepting the applications more than a year ago but their consideration requires Justice Department approval and the agency […]

Read More - -

Tags: , , ,

Drug-Centric Federal Agencies and Colorado Springs Officials Hold Secret Meeting

Officials from the Department of Justice, the White House Office of National Drug Policy and the DEA held a secret meeting on Wednesday with Colorado Springs Mayor John Suthers, members of the Colorado Springs Police Department, and the resident agent with the DEA, KKTV-11 reports. A local physician and a school district’s disciplinary director were […]

Read More - -

Tags: , ,

CBD Laws Are Convoluted Enough Without DEA Interjections

In a recent interview with the Cannabist, the DEA took aim at CBD production, specifically naming Charlotte’s Web – a low-THC cannabis strain produced and trademarked by CW Hemp oft used to treat children with epilepsy. In the statement, the federal law enforcement agency contends that the product, along with all other CBD products, is […]

Read More - -

Tags: , , ,

DEA Doubles Down: CBD Illegal

The Cannabist has published a series of statements by the Drug Enforcement Agency that further muddy the waters of the legality of CBD products, claiming that the products are “being illegally produced and marketed” in violation of the federal Controlled Substances, and Food, Drug, and Cosmetic Acts. “However, it is generally believed that the material […]

Read More - -

Tags: , ,

DEA Seeks to Have Lawsuit Against ‘Marijuana Extract’ Rule Tossed

The DEA is moving to have a lawsuit dismissed that challenges their December rule change which applies a Controlled Substances Number for “marijuana extract,” according to a report from the Cannabist. The lawsuit contends that the change moves hemp-derived products into the definition, running afoul of the 2014 federal Farm Bill. The lawsuit was filed on […]

Read More - -

Tags: , , , ,

DEA Approves Synthetic Cannabis Medication by Anti-Cannabis Pharmaceutical Giant

The Drug Enforcement Administration has approved Syndros, a cannabis-based medication developed by pharmaceutical company Insys Therapeutics, for Schedule II status under the Controlled Substances Act, according to a Chicago Tribune report. Syndros is an oral remedy that uses THC to treat nausea and vomiting, two of the most common symptoms caused by chemotherapy. The drug was pre-approved by the FDA […]

Read More - -

Tags: ,

DEA Removes Some Cannabis Myths from Website

The Drug Enforcement Agency has removed factually inaccurate information about cannabis from its website following public pressure and a legal request filed last year by Americans for Safe Access. The legal request, filed with the Department of Justice, argued that the DEA website contained more than 25 false statements about cannabis – a violation of […]

Read More - -

Tags: ,

You are viewing cannabis news and information related to DEA. View all cannabis news >>